p53: From Fundamental Biology to Clinical Applications in Cancer.
Maurizio CapuozzoMariachiara SantorsolaMarco BocchettiFrancesco PerriMarco CascellaVincenza GranataVenere CelottoOreste GualilloAlessia Maria CossuGuglielmo NastiMichele CaragliaAlessandro OttaianoPublished in: Biology (2022)
p53 tumour suppressor gene is our major barrier against neoplastic transformation. It is involved in many cellular functions, including cell cycle arrest, senescence, DNA repair, apoptosis, autophagy, cell metabolism, ferroptosis, immune system regulation, generation of reactive oxygen species, mitochondrial function, global regulation of gene expression, miRNAs, etc. Its crucial importance is denounced by the high percentage of amino acid sequence identity between very different species (Homo sapiens, Drosophila melanogaster, Rattus norvegicus, Danio rerio, Canis lupus familiaris, Gekko japonicus). Many of its activities allowed life on Earth (e.g., repair from radiation-induced DNA damage) and directly contribute to its tumour suppressor function. In this review, we provide paramount information on p53, from its discovery, which is an interesting paradigm of science evolution, to potential clinical applications in anti-cancer treatment. The description of the fundamental biology of p53 is enriched by specific information on the structure and function of the protein as well by tumour/host evolutionistic perspectives of its role.
Keyphrases
- dna damage
- cell cycle arrest
- cell death
- dna repair
- radiation induced
- amino acid
- oxidative stress
- gene expression
- drosophila melanogaster
- reactive oxygen species
- pi k akt
- dna damage response
- endoplasmic reticulum stress
- radiation therapy
- systemic lupus erythematosus
- dna methylation
- papillary thyroid
- public health
- health information
- single cell
- signaling pathway
- small molecule
- genome wide
- human health
- disease activity
- high throughput
- binding protein
- stem cells
- endothelial cells
- protein protein
- risk assessment